Laboratory of Veterinary Public Health, Department of Veterinary Medical Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo, 113-8657, Japan.
Department of Veterinary Science, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo, 162-8640, Japan.
Sci Rep. 2019 Jun 24;9(1):9193. doi: 10.1038/s41598-019-45412-8.
Tularemia is a severe infectious zoonotic disease caused by Francisella tularensis. Although F. tularensis is considered to be a potential biological weapon due to its high infectivity and mortality rate, no vaccine has been currently licensed. Recently, we reported that F. tularensis SCHU P9 derived ΔpdpC strain lacking the pathogenicity determinant protein C gene conferred stable and good protection in a mouse lethal model. In this study, the protective effect of ΔpdpC was evaluated using a monkey lethal model. Two cynomolgus macaques (Macaca fascicularis) intratracheally challenged with the virulent strain SCHU P9 were euthanized on 7 and 11 days post-challenge after the development of severe clinical signs. The bacterial replication in alveolar macrophages and type II epithelial cells in the lungs would cause severe pneumonia accompanied by necrosis. Conversely, two animals subcutaneously immunized with ΔpdpC survived 3 weeks after SCHU P9 challenge. Though one of the two animals developed mild symptoms of tularemia, bacterial replication was limited in the respiratory organs, which may be due to a high level of humoral and cellular immune responses against F. tularensis. These results suggest that the ΔpdpC mutant would be a safe and promising candidate as a live attenuated tularemia vaccine.
兔热病是一种由土拉弗朗西斯菌引起的严重传染性人畜共患病。尽管由于其高传染性和高死亡率,土拉弗朗西斯菌被认为是一种潜在的生物武器,但目前还没有获得许可的疫苗。最近,我们报道了一种缺乏致病性决定蛋白 C 基因的土拉弗朗西斯菌 SCHU P9ΔpdpC 株,在小鼠致死模型中具有稳定和良好的保护作用。在这项研究中,我们使用猴致死模型评估了ΔpdpC 的保护作用。两只食蟹猴(Macaca fascicularis)通过气管内攻毒,用强毒株 SCHU P9 感染,在出现严重临床症状后第 7 和 11 天处死。肺部肺泡巨噬细胞和 II 型上皮细胞中的细菌复制会导致严重的肺炎伴坏死。相反,用ΔpdpC 皮下免疫的两只动物在 SCHU P9 攻击后 3 周存活。尽管其中一只动物出现了轻度的兔热病症状,但细菌在呼吸道中的复制受到限制,这可能是由于针对土拉弗朗西斯菌的体液和细胞免疫反应水平较高。这些结果表明,ΔpdpC 突变体可能是一种安全且有前途的活减毒兔热病疫苗候选物。